Related Experiment Video
Updated: Apr 26, 2026
04:38
A Middle Cerebral Artery Occlusion Technique for Inducing Post-stroke Depression in Rats
Published on: May 22, 2019
9.4K
Understanding and preventing the development of post-stroke dementia
Masafumi Ihara1, Raj N Kalaria
1Department of Stroke and Cerebrovascular Diseases, National Cerebral and Cardiovascular Center, 5-7-1 Fujishiro-dai, Suita, Osaka 565-8565, Japan.
Expert Review of Neurotherapeutics
|August 9, 2014
Summary
Post-stroke dementia (PSD) is often vascular dementia. Controlling vascular risk factors and preventing recurrent strokes are key to reducing cognitive decline after stroke, though prevention trials are needed.
Area of Science:
- Neurology
- Gerontology
- Vascular Medicine
Background:
- Post-stroke dementia (PSD) is a recognized clinical condition.
- Most cases of PSD are now understood to be a form of vascular dementia.
- Vascular factors are strongly linked to dementia development.
Purpose of the Study:
- To review the relationship between vascular factors and dementia.
- To highlight the need for intervention and prevention strategies for PSD.
- To discuss the current limitations in preventing PSD.
Main Methods:
- Review of existing literature on post-stroke dementia.
- Analysis of the role of vascular risk factors in cognitive decline.
- Evaluation of the efficacy of current clinical trials for PSD prevention.
Main Results:
- Published clinical trials on PSD prevention have yielded limited success.
- Pharmacological prevention of PSD remains largely unproven.
- Controlling vascular disease risk and preventing recurrent strokes are crucial.
Conclusions:
- Effective management of vascular disease is paramount for reducing cognitive decline post-stroke.
- Further primary prevention trials focusing on lifestyle interventions are warranted.
- Advanced imaging and analysis techniques are essential for understanding PSD mechanisms and improving treatments.
Keywords:
Alzheimer’s diseasecognitive impairmentdementiamicroinfarctneuroimagingpost-stroke dementiastrokevascular dementiawhite matterMore Related Videos
07:42Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients
Published on: December 16, 2022
3.1K
09:45Motor and Hippocampal Dependent Spatial Learning and Reference Memory Assessment in a Transgenic Rat Model of Alzheimer's Disease with Stroke
Published on: March 22, 2016
9.8K
Related Concept Videos
01:22Dementia l: Introduction
29
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
29
01:30Dementia
681
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
681
01:26Alzheimer's Disease: Overview
1.7K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K
01:15Ischemic Stroke l: Introduction
29
Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
29
01:22Alzheimer's Disease: Treatment
1.3K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.3K
01:29Alzheimer Disease l: Introduction
19
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
19